Similar articles for PMID: 33188151

Year	Number of Results
2009	3
2010	2
2011	1
2012	3
2013	3
2014	2
2015	7
2016	8
2017	13
2018	18
2019	24
2020	23
2021	15
2022	14
2023	2
2024	0

1

Positive Predictive Value and Correct Detection Rate of ¹⁸F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard.

Chantadisai M, Buschner G, Krönke M, Rauscher I, Langbein T, Nekolla SG, Schiller K, Heck MM, Maurer T, Wurzer A, Wester HJ, D'Alessandria C, Weber W, Eiber M. Chantadisai M, et al. J Nucl Med. 2021 Jul 1;62(7):968-974. doi: 10.2967/jnumed.120.255661. Epub 2020 Nov 13. J Nucl Med. 2021. PMID: 33188151 Free article.

2

¹⁸F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.

Eiber M, Kroenke M, Wurzer A, Ulbrich L, Jooß L, Maurer T, Horn T, Schiller K, Langbein T, Buschner G, Wester HJ, Weber W. Eiber M, et al. J Nucl Med. 2020 May;61(5):696-701. doi: 10.2967/jnumed.119.234914. Epub 2019 Dec 13. J Nucl Med. 2020. PMID: 31836682 Free PMC article.

3

¹⁸F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study.

Ilhan H, Kroenke M, Wurzer A, Unterrainer M, Heck M, Belka C, Knorr K, Langbein T, Rauscher I, Schmidt-Hegemann NS, Schiller K, Bartenstein P, Wester HJ, Eiber M. Ilhan H, et al. J Nucl Med. 2022 Aug;63(8):1208-1214. doi: 10.2967/jnumed.121.262861. Epub 2022 Mar 10. J Nucl Med. 2022. PMID: 35273094 Free PMC article.

4

Detection efficacy of ¹⁸F-rhPSMA-7.3 PET/CT and impact on patient management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and prior to potential salvage treatment.

Rauscher I, Karimzadeh A, Schiller K, Horn T, D'Alessandria C, Franz C, Wörther H, Nguyen N, Combs SE, Weber WA, Eiber M. Rauscher I, et al. J Nucl Med. 2021 Mar 12;62(12):1719-26. doi: 10.2967/jnumed.120.260091. Online ahead of print. J Nucl Med. 2021. PMID: 33712531 Free PMC article.

5

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

6

⁶⁸Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.

Ceci F, Castellucci P, Graziani T, Farolfi A, Fonti C, Lodi F, Fanti S. Ceci F, et al. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):31-39. doi: 10.1007/s00259-018-4189-7. Epub 2018 Oct 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 30350010 Clinical Trial.

7

Early lesion detection with ¹⁸F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer.

Wondergem M, Jansen BHE, van der Zant FM, van der Sluis TM, Knol RJJ, van Kalmthout LWM, Hoekstra OS, van Moorselaar RJA, Oprea-Lager DE, Vis AN. Wondergem M, et al. Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1911-1918. doi: 10.1007/s00259-019-04385-6. Epub 2019 Jun 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 31230088 Free PMC article.

8

⁶⁸Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy.

Farolfi A, Ceci F, Castellucci P, Graziani T, Siepe G, Lambertini A, Schiavina R, Lodi F, Morganti AG, Fanti S. Farolfi A, et al. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):11-19. doi: 10.1007/s00259-018-4066-4. Epub 2018 Jun 15. Eur J Nucl Med Mol Imaging. 2019. PMID: 29905907

9

Validation of ¹⁸F-rhPSMA-7 and ¹⁸F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer.

Kroenke M, Schweiger L, Horn T, Haller B, Schwamborn K, Wurzer A, Maurer T, Wester HJ, Eiber M, Rauscher I. Kroenke M, et al. J Nucl Med. 2022 Dec;63(12):1809-1814. doi: 10.2967/jnumed.121.263707. Epub 2022 Apr 7. J Nucl Med. 2022. PMID: 35393348 Free PMC article.

10

Diagnostic accuracy of [¹⁸F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer.

Mingels C, Bohn KP, Rominger A, Afshar-Oromieh A, Alberts I. Mingels C, et al. Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2436-2444. doi: 10.1007/s00259-022-05693-0. Epub 2022 Jan 24. Eur J Nucl Med Mol Imaging. 2022. PMID: 35067735 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year